Literature DB >> 22914733

Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.

Cuiling Lu1, Li Lin, Huiping Tan, Hao Wu, Stephanie L Sherman, Fei Gao, Peng Jin, Dahua Chen.   

Abstract

Spontaneous 46,XX primary ovarian insufficiency (POI), also known as 'premature menopause' or 'premature ovarian failure', refers to ovarian dysfunction that results in a range of abnormalities, from infertility to early menopause as the end stage. The most common known genetic cause of POI is the expansion of a CGG repeat to 55-199 copies (premutation) in the 5' untranslated region in the X-linked fragile X mental retardation 1 (FMR1) gene. POI associated with the FMR1 premutation is referred to as fragile X-associated POI (FXPOI). Here, we characterize a mouse model carrying the human FMR1 premutation allele and show that FMR1 premutation RNA can cause a reduction in the number of growing follicles in ovaries and is sufficient to impair female fertility. Alterations in selective serum hormone levels, including FSH, LH and 17β-estradiol, are seen in this mouse model, which mimics findings in humans. In addition, we also find that LH-induced ovulation-related gene expression is specifically altered. Finally, we show that the FMR1 premutation allele can lead to reduced phosphorylation of Akt and mTOR proteins. These results together suggest that FMR1 premutation RNA could cause the POI associated with FMR1 premutation carriers, and the Akt/mTOR pathway may serve as a therapeutic target for FXPOI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914733      PMCID: PMC3490511          DOI: 10.1093/hmg/dds348

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

1.  Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?

Authors:  S L Sherman
Journal:  Am J Hum Genet       Date:  2000-06-12       Impact factor: 11.025

2.  Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.

Authors:  I J Gonzalez-Robayna; A E Falender; S Ochsner; G L Firestone; J S Richards
Journal:  Mol Endocrinol       Date:  2000-08

3.  Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.

Authors:  A Kenneson; F Zhang; C H Hagedorn; S T Warren
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

4.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

5.  Proposal for a classification of oocytes and follicles in the mouse ovary.

Authors:  T Pedersen; H Peters
Journal:  J Reprod Fertil       Date:  1968-12

6.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Authors:  Rob Willemsen; Marianne Hoogeveen-Westerveld; Surya Reis; Joan Holstege; Lies-Anne W F M Severijnen; Ingeborg M Nieuwenhuizen; Mariette Schrier; Leontine van Unen; Flora Tassone; Andre T Hoogeveen; Paul J Hagerman; Edwin J Mientjes; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

7.  Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice.

Authors:  Andrea M Peier; David L Nelson
Journal:  Genomics       Date:  2002-10       Impact factor: 5.736

Review 8.  The fragile X premutation: into the phenotypic fold.

Authors:  Randi J Hagerman; Paul J Hagerman
Journal:  Curr Opin Genet Dev       Date:  2002-06       Impact factor: 5.578

9.  RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila.

Authors:  Peng Jin; Daniela C Zarnescu; Fuping Zhang; Christopher E Pearson; John C Lucchesi; Kevin Moses; Stephen T Warren
Journal:  Neuron       Date:  2003-08-28       Impact factor: 17.173

10.  Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.

Authors:  Hena Alam; Evelyn T Maizels; Youngkyu Park; Shail Ghaey; Zachary J Feiger; Navdeep S Chandel; Mary Hunzicker-Dunn
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

View more
  35 in total

Review 1.  The impact of FMR1 gene mutations on human reproduction and development: a systematic review.

Authors:  Vincenzo Noto; Conor Harrity; David Walsh; Kevin Marron
Journal:  J Assist Reprod Genet       Date:  2016-07-18       Impact factor: 3.412

Review 2.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 3.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

4.  Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.

Authors:  Marsha R Mailick; Jinkuk Hong; Jan Greenberg; Leann Smith; Stephanie Sherman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-10-25       Impact factor: 3.568

5.  Use of human-derived stem cells to create a novel, in vitro model designed to explore FMR1 CGG repeat instability amongst female premutation carriers.

Authors:  Stephanie L F Gustin; Guangwen Wang; Valerie M Baker; Gary Latham; Vittorio Sebastiano
Journal:  J Assist Reprod Genet       Date:  2018-06-20       Impact factor: 3.412

6.  FMR1 CGG expansions: prevalence and sex ratios.

Authors:  Matthew J Maenner; Mei W Baker; Karl W Broman; Jianan Tian; Janel K Barnes; Anne Atkins; Elizabeth McPherson; Jinkuk Hong; Murray H Brilliant; Marsha R Mailick
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-06-05       Impact factor: 3.568

7.  Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.

Authors:  Carola Conca Dioguardi; Bahar Uslu; Monique Haynes; Meltem Kurus; Mehmet Gul; De-Qiang Miao; Lucia De Santis; Maurizio Ferrari; Stefania Bellone; Alessandro Santin; Cecilia Giulivi; Gloria Hoffman; Karen Usdin; Joshua Johnson
Journal:  Mol Hum Reprod       Date:  2016-03-09       Impact factor: 4.025

8.  Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI).

Authors:  Heather S Hipp; Krista H Charen; Jessica B Spencer; Emily G Allen; Stephanie L Sherman
Journal:  Menopause       Date:  2016-09       Impact factor: 2.953

9.  Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.

Authors:  Jennie K Kline; Ann M Kinney; Bruce Levin; Stephen A Brown; Andrew G Hadd; Dorothy Warburton
Journal:  Menopause       Date:  2014-07       Impact factor: 2.953

Review 10.  Genomic markers of ovarian reserve.

Authors:  Michelle A Wood; Aleksandar Rajkovic
Journal:  Semin Reprod Med       Date:  2013-10-07       Impact factor: 1.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.